Improved one-tube RT-PCR method for simultaneous detection and genotyping of duck hepatitis A virus subtypes 1 and 3

PLoS One. 2019 Aug 1;14(8):e0219750. doi: 10.1371/journal.pone.0219750. eCollection 2019.

Abstract

Background: The cocirculation of duck hepatitis A virus subtypes 1 (DHAV-1) and 3 (DHAV-3) in ducklings has resulted in significant economic losses. Ducklings with DHAV-1 or DHAV-3 infection show similar clinical signs and gross lesions; hence, it is important to identify the viral subtypes in infected ducklings as early as possible for better clinical management.

Methods and results: Based on multiple 5' noncoding region (5'-NCR) sequences of DHAV-1 and DHAV-3 strain alignments, universal and type-specific primers were designed and synthesized. With three primers in one-tube reverse transcription-PCR (RT-PCR), reference DHAV-1 and DHAV-3 isolates ranging over 60 years and across many different countries were successfully amplified, indicating that the primer sequences were completely conserved. The sequence results and the sizes of amplicons from reference DHAV-1 and DHAV-3 isolates are completely correlated with their subtypes. Moreover, with this one-tube RT-PCR system, amplicon sizes from liver samples of reference DHAV-1- or DHAV-3-infected birds fit closely with their subtypes, which was determined by virus isolation and neutralization testing. No other duck-origin RNA viruses were detected. The sensitivity of viral RNA detection was 10 pg. With this system, 20% subtype 1, 45% subtype 3, and 9% coinfection of two subtypes were detected in 55 clinical samples.

Conclusions and significance: This novel approach could be used for rapidly typing DHAV-1 or DHAV-3 infection in routine clinical surveillance or epidemiological screening.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Ducks / virology*
  • Genotype
  • Hepatitis Virus, Duck / classification*
  • Hepatitis Virus, Duck / genetics*
  • Hepatitis Virus, Duck / isolation & purification
  • Hepatitis, Viral, Animal / diagnosis*
  • Hepatitis, Viral, Animal / virology
  • Picornaviridae Infections / diagnosis
  • Picornaviridae Infections / veterinary*
  • Picornaviridae Infections / virology
  • Poultry Diseases / epidemiology*
  • Poultry Diseases / virology
  • Reverse Transcriptase Polymerase Chain Reaction / veterinary*

Grants and funding

This work was supported by the National Natural Science Foundation of China (31670153), National Key Technologies R&D Program (2016YFD0500100), CAAS-XTCX2016011-04-9, and AGVSKL-ZD-201804 from the State Key Lab of Genetically Engineered Veterinary Vaccine. Yun Zhang supervised and provided the funding the National Natural Science Foundation of China (31670153), National Key Technologies R&D Program (2016YFD0500100), and CAAS-XTCX2016011-04-9 and Ming Liu supervised and provided the funding AGVSKL-ZD-201804 for the study. We declared that commercial company eBio of Qingdao did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. It only provided financial support in the form of research materials. The specific roles of DYZ and CGF are articulated in the ‘author contributions’ section.